Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-30 @ 7:36 AM
Study NCT ID:
NCT00520169
Status:
COMPLETED
Last Update Posted:
2008-01-10
First Post:
2007-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine
Sponsor:
Javelin Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KET-PK-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Javelin Pharmaceuticals
Old Organization:
Javelin Pharmaceuticals